Common TitleATTAIN
Official Title Simeprevir versus Telaprevir with Peginterferon and Ribavirin in Previous Null or Partial Responders with Chronic Hepatitis C Virus Genotype 1 Infection (ATTAIN): A Randomised, Double-Blind, Non-Inferiority Phase 3 Trial
Phase Phase III
ClinicalTrials.gov NCT01485991
Treatments
Simeprevir
Simeprevir
Tradename:OlysioOther Names:SMVClass:DiscontinuedFunding
IndustryJanssen